Brief: Expres2ion And Attana Have Signed A Development And Supply Agreement

ATTANA AB

24/09/2020 07:04

Sept 24 (Reuters) - Attana AB  ATANA.NGM :
    * EXPRES2ION AND ATTANA HAVE SIGNED A DEVELOPMENT AND SUPPLY AGREEMENT
    * EXPRES2ION BIOTECH HOLDING AB - FIRST TARGET PROTEIN WILL BE EXPRES2ION-PRODUCED
SARS-COV-2
SPIKE AND RECEPTOR-BINDING-DOMAIN (RBD) ANTIGEN USED IN EXPRES2ION'S COVID-19 VACCINE PROGRAM
    * EXPRES2ION BIOTECH HOLDING AB - PARTIES ARE NOT DISCLOSING COMMERCIAL TERMS OF AGREEMENT.
    * EXPRES2ION BIOTECH HOLDING AB - AND ATTANA AB HAVE TODAY SIGNED A HEADS OF TERMS AGREEMENT
REGARDING DEVELOPMENT AND SUPPLY OF NOVEL EXPRES2ION PROTEINS TO ATTANA

Source text for Eikon:  ID:nWkr3Ygngs 
Further company coverage:  ATANA.NGM 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))